<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="PPV3 of Suspicious Breast MRI Findings" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/ppv3-of-suspicious-breast-mri-findings/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/ppv3-of-suspicious-breast-mri-findings/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2014-11-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="PPV3 of Suspicious Breast MRI Findings" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2014-11-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"PPV3 of Suspicious Breast MRI Findings","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/ppv3-of-suspicious-breast-mri-findings/"},"url":"https://clinicaltree.github.io/posts/ppv3-of-suspicious-breast-mri-findings/"}</script><title>PPV3 of Suspicious Breast MRI Findings | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>PPV3 of Suspicious Breast MRI Findings</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>PPV3 of Suspicious Breast MRI Findings</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1417366800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Nov 30, 2014 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Haydan Smith</a> </em>, <em> <a href="">Alison L. Chetlen DO</a> </em>, <em> <a href="">Susann Schetter DO</a> </em>, <em> <a href="">Julie Mack MD</a> </em>, <em> <a href="">Meredith Watts MD</a> </em>, <em> <a href="">Junjia (Jay) Zhu PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2957 words"> <em>16 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Magnetic resonance imaging (MRI) characteristics of Breast Imaging Reporting and Data System (BI-RADS) 4 and 5 lesions were evaluated to identify characteristics that may improve the positive predictive value (PPV) of a biopsy.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>MRI BI-RADS 4 or 5 breast findings in 101 women who underwent biopsy leading to a diagnosis of cancer within 1 year (PPV 3 ; <em>n</em> = 115 cases) were reviewed. Patient history, lesion morphology, enhancement pattern and kinetics, and T 2 characteristics were examined.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The PPV 3 of all BI-RADS 4 and 5 breast lesions seen on MRI was 22.6% (26 of 115). Excluding lesions with second-look imaging correlates decreased the PPV 3 to 11.8% (6/51). Of the MRI-guided biopsies, 20.9% (24 of 115) yielded a high-risk lesion, altering surgical management. MRI lesion type did not significantly affect the PPV 3 : the PPV 3 was 26.3% (15 of 57) for masses, 21.4% (9 of 42) for non mass enhancement (NME) and 12.5% (2 of 16) for suspicious foci. The PPV 3 for lesions found on diagnostic MRI in women with newly diagnosed cancer was 30.8% (20 of 65) which was statistically significantly greater compared to a PPV 3 of 11.9% (5 of 42) for lesions identified on high-risk screening MRI.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Suspicious MRI findings identified on a second-look examination are more likely malignant than those seen only on MRI. Suspicious MRI findings discovered in patients with concurrent malignancy have a greater PPV 3 than those detected on high-risk screening MRIs. However, the type of MRI finding (mass vs. NME vs. foci) does not significantly affect the PPV 3 and should not be used as a discriminator for determining biopsy threshold.</p><p>Breast magnetic resonance imaging (MRI) is a highly sensitive imaging tool in the detection and characterization of breast cancer . MRI is useful in the evaluation of women with a new diagnosis of breast cancer to determine the extent of disease and screen the contralateral breast when there is a new diagnosis . There is also evidence that supplemental screening with MRI when women have a lifetime chance of malignancy of 20% is beneficial . Breast MRI is highly sensitive but less specific than ultrasound (US) or mammography . As a result, the recommendation for biopsy of a suspicious lesion may yield cancer in a lesser percentage of patients than when mammograms or US are used to diagnose cancer. Therefore, suspicious MRI findings would be expected to have a decreased positive predictive value (PPV 3 ) when compared to the PPV for suspicious findings identified on mammography and US.</p><p>There are a number of MRI characteristics that are considered predictive of malignancy, such as Breast Imaging Reporting and Data System (BI-RADS) assessment , lesion size , enhancement pattern , and enhancement kinetics . However, there is considerable overlap between suspicious and benign MRI characteristics.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="method-of-biopsy-of-suspicious-mri-findings"><span class="mr-2">Method of Biopsy of Suspicious MRI Findings</span><a href="#method-of-biopsy-of-suspicious-mri-findings" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/PPV3ofSuspiciousBreastMRIFindings/0_1s20S1076633214002761.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/PPV3ofSuspiciousBreastMRIFindings/0_1s20S1076633214002761.jpg" alt="Figure 1, Method of biopsy of suspicious MRI findings: MRI BI-RADS 4 and 5 findings and subsequent method of biopsy and histologic results. High risk refers to the histologic classification of the lesion (ie, lobular neoplasia, atypical ductal hyperplasia, radial scar, papillary lesion). BI-RADS, Breast Imaging Reporting and Data System; MRI, magnetic resonance imaging." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="histologic-outcome-of-suspicious-mri-findings"><span class="mr-2">Histologic Outcome of Suspicious MRI Findings</span><a href="#histologic-outcome-of-suspicious-mri-findings" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/PPV3ofSuspiciousBreastMRIFindings/1_1s20S1076633214002761.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/PPV3ofSuspiciousBreastMRIFindings/1_1s20S1076633214002761.jpg" alt="Figure 2, Histologic outcome of suspicious MRI findings: Malignancies detected on breast MRI and subsequent histology according to MRI morphology. High risk refers to the histologic classification of the lesion (ie, lobular neoplasia, atypical ductal hyperplasia (ADH), radial scar, papillary lesion). DCIS, ductal carcinoma in situ; MRI, magnetic resonance imaging; NME, non mass enhancement." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-characteristics-of-suspicious-mri-findings"><span class="mr-2">Imaging Characteristics of Suspicious MRI Findings</span><a href="#imaging-characteristics-of-suspicious-mri-findings" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Characteristics of Biopsy-Proven Malignancies</p><p>Characteristic Number of Carcinomas Invasive or In Situ Invasive In Situ Lesion type Mass 15 11 4 NME 9 5 4 Foci 2 2 0 Pattern of enhancement Homogeneous 15 11 4 Heterogeneous 10 6 4 Peripheral 1 1 0 Early enhancement kinetics Rapid 13 9 4 Medium 11 8 3 Slow 2 1 1 Late enhancement kinetics Persistent 5 3 2 Plateau 10 7 3 Washout 11 8 3 T 1 Hyperintense 0 0 0 Hypointense 13 10 3 Isointense 13 8 5 T 2 Hyperintense 16 11 5 Hypointense 1 1 0 Isointense 7 5 2 Slightly hyperintense 2 1 1 Total 26 18 8</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="morphology"><span class="mr-2">Morphology</span><a href="#morphology" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/PPV3ofSuspiciousBreastMRIFindings/2_1s20S1076633214002761.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/PPV3ofSuspiciousBreastMRIFindings/2_1s20S1076633214002761.jpg" alt="Figure 3, Imaging characteristics of suspicious MRI findings: Suspicious MRI findings according to MRI morphologic type (mass, NME, or focus) with subsequent method of biopsy and pathologic results. High risk refers to the histologic classification of the lesion (ie, lobular neoplasia, atypical ductal hyperplasia [ADH], radial scar, papillary lesion). BI-RADS, Breast Imaging Reporting and Data System; MRI, magnetic resonance imaging." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="masses"><span class="mr-2">Masses</span><a href="#masses" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="non-mass-enhancement"><span class="mr-2">Non Mass Enhancement</span><a href="#non-mass-enhancement" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="foci"><span class="mr-2">Foci</span><a href="#foci" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="pattern-of-enhancement"><span class="mr-2">Pattern of Enhancement</span><a href="#pattern-of-enhancement" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="enhancement-kinetics"><span class="mr-2">Enhancement Kinetics</span><a href="#enhancement-kinetics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="t--2--characteristics"><span class="mr-2">T 2 Characteristics</span><a href="#t--2--characteristics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="indication-for-breast-mris"><span class="mr-2">Indication for Breast MRIs</span><a href="#indication-for-breast-mris" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="suspicious-mri-findings-that-did-not-enhance-on-day-of-biopsy"><span class="mr-2">Suspicious MRI Findings That Did Not Enhance on Day of Biopsy</span><a href="#suspicious-mri-findings-that-did-not-enhance-on-day-of-biopsy" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="method-of-biopsy-of-suspicious-mri-findings-1"><span class="mr-2">Method of Biopsy of Suspicious MRI Findings</span><a href="#method-of-biopsy-of-suspicious-mri-findings-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-characteristics-of-suspicious-mri-findings-1"><span class="mr-2">Imaging Characteristics of Suspicious MRI Findings</span><a href="#imaging-characteristics-of-suspicious-mri-findings-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/PPV3ofSuspiciousBreastMRIFindings/3_1s20S1076633214002761.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/PPV3ofSuspiciousBreastMRIFindings/3_1s20S1076633214002761.jpg" alt="Figure 4, Two different patients with newly diagnosed breast cancer with contralateral suspicious areas of NME, with similar appearing axial T 1 fat-saturated postcontrast subtraction images. Both areas underwent MRI-guided biopsy. (a) Axial T 1 fat-saturated postcontrast subtraction image of a 75-year-old female with newly diagnosed left breast invasive lobular carcinoma (ILC) demonstrates an additional suspicious finding in her contralateral breast. A focal area of clumped NME was seen in the right breast 9 o′ clock radian at middle depth ( arrow ). This NME was T 2 hyperintense and demonstrated moderate initial enhancement kinetics with plateau. There was no mammographic correlate. Histology from MRI-guided biopsy was malignant, demonstrating ILC and lobular carcinoma in situ (LCIS). (b) Axial T 1 fat-saturated postcontrast subtraction image of a 46-year-old woman with newly diagnosed invasive ductal carcinoma and lobular carcinoma in situ (LCIS) in the right breast. An additional lesion was found in the left breast ( arrow ) described as clumped heterogeneous NME. This finding was also hyperintense on T 2 and demonstrated rapid initial uptake of contrast with plateau enhancement kinetics. There was no mammographic correlate. Histology from MRI-guided biopsy was benign, demonstrating fibrocystic change and usual ductal hyperplasia. MRI, magnetic resonance imaging; NME, non mass enhancement." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="morphology-1"><span class="mr-2">Morphology</span><a href="#morphology-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="pattern-of-enhancement-1"><span class="mr-2">Pattern of Enhancement</span><a href="#pattern-of-enhancement-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="enhancement-kinetics-1"><span class="mr-2">Enhancement Kinetics</span><a href="#enhancement-kinetics-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="t--2--characteristics-1"><span class="mr-2">T 2 Characteristics</span><a href="#t--2--characteristics-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="indication-for-breast-mris-1"><span class="mr-2">Indication for Breast MRIs</span><a href="#indication-for-breast-mris-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="strengths-of-the-study"><span class="mr-2">Strengths of the Study</span><a href="#strengths-of-the-study" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="limitations-of-the-study"><span class="mr-2">Limitations of the Study</span><a href="#limitations-of-the-study" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Lehman C.D., Blume J.D., Weatherall P., et. al.: Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005; 103: pp. 1898-1905.</p><li><p>2. Lehman C.D., Schnall M.D.: Imaging in breast cancer: magnetic resonance imaging. Breast Cancer Research 2005; 7: pp. 215.</p><li><p>3. Lehman C.D., Schnall M.D., Kuhl C.K., et. al.: Report of the Working Groups on Breast MRI: Report of the High-Risk Screening Group. The Breast Journal 2004; 10: pp. S9-S12.</p><li><p>4. Liberman L., Mason G., Morris E.A., et. al.: Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. American Journal of Roentgenology 2006; 186: pp. 426-430.</p><li><p>5. DeMartini W.B., Lehman C.D., Peacock S., et. al.: Computer-aided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy 1 . Academic Radiology 2005; 12: pp. 806-814.</p><li><p>6. Harms S., Flamig D., Hesley K., et. al.: MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187: pp. 493-501.</p><li><p>7. Lehman C.D., Blume J.D., Thickman D., et. al.: Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. Journal of Surgical Oncology 2005; 92: pp. 9-15.</p><li><p>8. Schnall M.D., Blume J., Bluemke D.A., et. al.: MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. Journal of Surgical Oncology 2005; 92: pp. 32-38.</p><li><p>9. Lehman C.D., Gatsonis C., Kuhl C.K., et. al.: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. New England Journal of Medicine 2007; 356: pp. 1295-1303.</p><li><p>10. Lee S.G., Orel S.G., Woo I.J., et. al.: MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003; 226: pp. 773-778.</p><li><p>11. Liberman L., Morris E.A., Dershaw D.D., et. al.: MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. American Journal of Roentgenology 2003; 180: pp. 901-910.</p><li><p>12. Institute NC. Available at: https://irep.nci.nih.gov/radrat .</p><li><p>13. Lee C.H., Dershaw D.D., Kopans D., et. al.: Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. Journal of the American College of Radiology 2010; 7: pp. 18-27.</p><li><p>14. Sardanelli F., Podo F., D’Agnolo G., et. al.: Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007; 242: pp. 698-715.</p><li><p>15. Leach M.O., Boggis C., Dixon A., et. al.: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005; 365: pp. 1769-1778.</p><li><p>16. Warner E., Plewes D.B., Hill K.A., et. al.: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292: pp. 1317-1325.</p><li><p>17. Kriege M., Brekelmans C.T., Boetes C., et. al.: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. New England Journal of Medicine 2004; 351: pp. 427-437.</p><li><p>18. Causer P.A., Jong R.A., Warner E., et. al.: Breast cancers detected with imaging screening in the BRCA population: emphasis on MR imaging with histopathologic correlation. Radiographics 2007; 27: pp. S165-S182.</p><li><p>19. Kuhl C.K., Schmutzler R.K., Leutner C.C., et. al.: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000; 215: pp. 267-279.</p><li><p>20. Lehman C.D., Isaacs C., Schnall M.D., et. al.: Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007; 244: pp. 381-388.</p><li><p>21. Kuhl C.: The current status of breast MR imaging part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007; 244: pp. 356-378.</p><li><p>22. Goscin C.P., Berman C.G., Clark R.A.: Magnetic resonance imaging of the breast. Cancer control 2001; 8: pp. 399-406.</p><li><p>23. Peters N.H., Rinkes I.H.B., Zuithoff N.P., et. al.: Meta-Analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008; 246: pp. 116-124.</p><li><p>24. Mahoney M.C., Gatsonis C., Hanna L., et. al.: Positive predictive value of BI-RADS MR imaging. Radiology 2012; 264: pp. 51-58.</p><li><p>25. Langer S.A., Horst K.C., Ikeda D.M., et. al.: Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?. The American Journal of Surgery 2005; 190: pp. 633-640.</p><li><p>26. Sakamoto N., Tozaki M., Higa K., et. al.: Categorization of non-mass-like breast lesions detected by MRI. Breast Cancer 2008; 15: pp. 241-246.</p><li><p>27. Liberman L., Morris E.A., Dershaw D.D., et. al.: Ductal enhancement on MR imaging of the breast. American Journal of Roentgenology 2003; 181: pp. 519-525.</p><li><p>28. Kuhl C.K., Mielcareck P., Klaschik S., et. al.: Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999; 211: pp. 101-110.</p><li><p>29. Macura K.J., Ouwerkerk R., Jacobs M.A., et. al.: Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics 2006; 26: pp. 1719-1734. quiz</p><li><p>30. Kuhl C.K., Bieling H.B., Gieseke J., et. al.: Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997; 203: pp. 137-144.</p><li><p>31. Müller-Schimpfle M., Ohmenhaüser K., Stoll P., et. al.: Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997; 203: pp. 145-149.</p><li><p>32. Delille J.P., Slanetz P.J., Yeh E.D., et. al.: Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. The breast journal 2005; 11: pp. 236-241.</p><li><p>33. (ACR) ACoR. Breast Imaging Reporting and Data System Atlas (BI-RADS® Atlas). 4th ed ed. Reston, Virginia 2003.</p><li><p>34. Naeger D.M., Kohi M.P., Webb E.M., et. al.: Correctly using sensitivity, specificity, and predictive values in clinical practice: how to avoid three common pitfalls. American Journal of Roentgenology 2013; 200: pp. W566-W570.</p><li><p>35. Yamaguchi K., Schacht D., Sennett C.A., et. al.: Decision making for breast lesions initially detected at contrast-enhanced breast MRI. American Journal of Roentgenology 2013; 201: pp. 1376-1385.</p><li><p>36. Han B.-K., Schnall M.D., Orel S.G., et. al.: Outcome of MRI-guided breast biopsy. American Journal of Roentgenology 2008; 191: pp. 1798-1804.</p><li><p>37. Arazi-Kleinman T., Skair-Levy M., Slonimsky E., et. al.: JOURNAL CLUB: is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results. American Journal of Roentgenology 2013; 201: pp. 919-927.</p><li><p>38. Morris E.A., Liberman L., Ballon D.J., et. al.: MRI of occult breast carcinoma in a high-risk population. American Journal of Roentgenology 2003; 181: pp. 619-626.</p><li><p>39. Warner E., Messersmith H., Causer P., et. al.: Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Annals of Internal Medicine 2008; 148: pp. 671-679.</p><li><p>40. Bassett L.W., Hendrick R.E.: Quality determinants of mammography: clinical practice guideline.2004.DIANE Publishing</p><li><p>41. Linda A., Zuiani C., Londero V., et. al.: Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size. The Breast 2008; 17: pp. 51-57.</p><li><p>42. DeMartini W.B., Eby P.R., Peacock S., et. al.: Utility of targeted sonography for breast lesions that were suspicious on MRI. American Journal of Roentgenology 2009; 192: pp. 1128-1134.</p><li><p>43. Abe H., Schmidt R.A., Shah R.N., et. al.: MR-directed (“Second-Look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. American Journal of Roentgenology 2010; 194: pp. 370-377.</p><li><p>44. Baltzer P.A., Benndorf M., Dietzel M., et. al.: False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. American Journal of Roentgenology 2010; 194: pp. 1658-1663.</p><li><p>45. Liberman L., Morris E.A., Lee M.J.-Y., et. al.: Breast lesions detected on MR imaging: features and positive predictive value. American Journal of Roentgenology 2002; 179: pp. 171-178.</p><li><p>46. Orel S., Mendonca M.H., Reynolds C., et. al.: MR imaging of ductal carcinoma in situ. Radiology 1997; 202: pp. 413-420.</p><li><p>47. Facius M., Renz D.M., Neubauer H., et. al.: Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Clinical Imaging 2007; 31: pp. 394-400.</p><li><p>48. Gutierrez R.L., DeMartini W.B., Eby P.R., et. al.: BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. American Journal of Roentgenology 2009; 193: pp. 994-1000.</p><li><p>49. Wedegärtner U., Bick U., Wörtler K., et. al.: Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria. European Radiology 2001; 11: pp. 1645-1650.</p><li><p>50. Kuhl C.K., Klaschik S., Mielcarek P., et. al.: Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI?. Journal of Magnetic Resonance Imaging : JMRI 1999; 9: pp. 187-196.</p><li><p>51. Malich A., Fischer D.R., Wurdinger S., et. al.: Potential MRI interpretation model: differentiation of benign from malignant breast masses. American Journal of Roentgenology 2005; 185: pp. 964-970.</p><li><p>52. Bartella L., Liberman L., Morris E.A., et. al.: Nonpalpable mammographically occult invasive breast cancers detected by MRI. American Journal of Roentgenology 2006; 186: pp. 865-870.</p><li><p>53. Gutierrez R.L., DeMartini W.B., Eby P., et. al.: Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions. Academic Radiology 2009; 16: pp. 1281-1285.</p><li><p>54. Bosmans H., Marshall N.: Radiation doses and risks associated with mammographic screening. Current Radiology Reports 2013; 1: pp. 30-38.</p><li><p>55. Wiratkapun C., Duke D., Nordmann A.S., et. al.: Indeterminate or suspicious breast lesions detected initially with MR imaging: value of MRI-directed breast ultrasound. Academic Radiology 2008; 15: pp. 618-625.</p><li><p>56. Hylton N. American College of Radiology Imaging Network ACRIN 6698 Diffusion weighted MR imaging biomarkers for assessment of breast cancer response to neoadjuvant treatment: a sub-study of the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis).</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-21/'>Volume 21</a>, <a href='/categories/issue-12/'>Issue 12</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=PPV3%20of%20Suspicious%20Breast%20MRI%20Findings%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fppv3-of-suspicious-breast-mri-findings%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=PPV3%20of%20Suspicious%20Breast%20MRI%20Findings%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fppv3-of-suspicious-breast-mri-findings%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fppv3-of-suspicious-breast-mri-findings%2F&text=PPV3%20of%20Suspicious%20Breast%20MRI%20Findings%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/assessment-of-repeatability-of-hyperpolarized-gas-mr-ventilation-functional-imaging-in-cystic-fibros/"><div class="card-body"> <em class="small" data-ts="1417366800" data-df="ll" > Nov 30, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessment of Repeatability of Hyperpolarized Gas MR Ventilation Functional Imaging in Cystic Fibrosis</h3><div class="text-muted small"><p> Rationale and Objectives Hyperpolarized (HP) gas magnetic resonance imaging (MRI) is an advanced imaging technique that provides high-resolution regional information on lung function without using...</p></div></div></a></div><div class="card"> <a href="/posts/automatic-segmentation-and-quantitative-analysis-of-white-matter-hyperintensities-on-flair-images-us/"><div class="card-body"> <em class="small" data-ts="1417366800" data-df="ll" > Nov 30, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automatic Segmentation and Quantitative Analysis of White Matter Hyperintensities on FLAIR Images Using Trimmed-Likelihood Estimator</h3><div class="text-muted small"><p> Rationale and Objectives Quantitative analysis of white matter hyperintensities (WMHs) on fluid-attenuated inversion recovery (FLAIR) images provides information for disease tracking, therapeutic ...</p></div></div></a></div><div class="card"> <a href="/posts/comparison-of-a-stationary-digital-breast-tomosynthesis-system-to-magnified-2d-mammography-using-bre/"><div class="card-body"> <em class="small" data-ts="1417366800" data-df="ll" > Nov 30, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Comparison of a Stationary Digital Breast Tomosynthesis System to Magnified 2D Mammography Using Breast Tissue Specimens</h3><div class="text-muted small"><p> Rational and Objectives The objective of this study was to compare the stationary digital breast tomosynthesis (s-DBT) system to a conventional mammography system in a study of breast specimens. R...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/magnetic-resonance-spectroscopy-features-of-heschl-s-gyri-in-patients-with-unilateral-acoustic-neuro/" class="btn btn-outline-primary" prompt="Older"><p>Magnetic Resonance Spectroscopy Features of Heschl's Gyri in Patients with Unilateral Acoustic Neuroma</p></a> <a href="/posts/prediction-of-aortic-enhancement-on-coronary-cta-images-using-a-test-bolus-of-diluted-contrast-mater/" class="btn btn-outline-primary" prompt="Newer"><p>Prediction of Aortic Enhancement on Coronary CTA Images Using a Test Bolus of Diluted Contrast Material</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
